HCID 10903732、化合物 → Lamivudine

HRID 342512

反応式

HRID 342512 の反応式
[NH2:1][C:2]1[CH:7]=[CH:6][N:5]([C@H:8]2[O:12][C@@H:11]([CH2:13][O:14]C(=O)C3C=CC=CC=3)[S:10][CH2:9]2)[C:4](=[O:23])[N:3]=1>CO>[NH2:1][C:2]1[CH:7]=[CH:6][N:5]([C@H:8]2[O:12][C@@H:11]([CH2:13][OH:14])[S:10][CH2:9]2)[C:4](=[O:23])[N:3]=1

参加物

3

反応物 1

HCID 10903732HCID 10903732、化合物2 回

生成物 1

HCID 60825Lamivudine収率 90.4%

試薬・触媒・溶媒 1

HCID 887Methanol溶媒

実験手順

A suspension of (cis)-4-amino-1-(2-benzoyloxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one (Intermediate 3) (8.19 g) and Amberlite IRA-400 (OH) resin (8.24 g) in methanol (250 ml) was stirred and heated to reflux for 11/4 h. Solids were removed by filtration then washed with methanol. The combined filtrates were evaporated. The residue was triturated with ethyl acetate (80 ml). The resulting white solid was collected by filtration to give the title product (5.09 g), 1H NMR (DMSO-d6) 3.04 (1H), 3.40 (1H), 3.73 (2H), 5.18 (1H), 5.29 (1H), 5.73 (1H), 6.21 (1H), 7.19 (2H), 7,81 (1H).

後処理

  1. temperatureheated
  2. temperatureto reflux for 11/4 h
  3. customSolids were removed by filtration
  4. washthen washed with methanol
  5. customThe combined filtrates were evaporated
  6. customThe residue was triturated with ethyl acetate (80 ml)
  7. filtrationThe resulting white solid was collected by filtration

出典と根拠

ORDレコード
ord-dfcad035ce1a425dbb61dbbca1cb6cce
出典データセット
uspto-grants-1999_01
特許番号
US05859021

関連ノート

読み込み中…